FindTrial
Sign In

Impact of vaccination on distribution of T cell subsets in antiretroviral-treated HIV-infected children

Efficacy and safety of Monovalent Influenza A (H1N1) 2009 Panenza in HIV-infected Thai children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20170501002
Enrollment
50
Registered
2017-05-01
Start date
2010-01-25
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alteration of T cell subsets.

Interventions

Two doses of influenza A H1N1 2009 vaccine were administered to the patients via an intramuscular route.
Experimental Biological/Vaccine
Monovalent Influenza A (H1N1) 2009 Panenza vaccine

Sponsors

Faculty of Medicine Siriraj Hospital
Lead Sponsor
Faculty of Medicine Siriraj Hospital
Collaborator

Eligibility

Sex/Gender
All
Age
6 Months to 18 Years

Inclusion criteria

Inclusion criteria: HIV-infected children receiving antiretroviral treatment

Exclusion criteria

Exclusion criteria: HIV-infected children not receiving antiretroviral treatment

Design outcomes

Primary

MeasureTime frame
Alteration of T cell subsets 2 years Vaccine influence—

Secondary

MeasureTime frame
CD4 count level 2 years Vaccine influence—

Countries

Thailand

Contacts

Public ContactNattawat Onlamoon

Faculty of Medicine Siriraj Hospital

nattawat.onl@mahidol.ac.th024192797

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026